SCHEMBL30465486

SCHEMBL30465486

CCc1ccncc1C(=O)OC

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.57
ALDH1A1 P00352 5/20 0.57
GLA P06280 2/20 0.57
GAA P10253 2/20 0.57
LMNA P02545 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
MAPK8 P45983 1/20 0.47
MAPK9 P45984 1/20 0.47
MAPK10 P53779 1/20 0.47
KMT2A Q03164 2/20 0.43
CYP46A1 Q9Y6A2 1/20 0.43
HSD17B10 Q99714 4/20 0.41
HPGD P15428 2/20 0.41
HTT P42858 2/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
NCOA1 Q15788 1/20 0.41
RCE1 Q9Y256 1/20 0.41
NCOA3 Q9Y6Q9 1/20 0.41
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4074620 1.00 KDM4E (0.57) KDM4EALDH1A1GLAGAALMNA
SCHEMBL17078728 0.86 ALDH1A1 (0.54) KDM4EALDH1A1GLAGAALMNA
SCHEMBL4317587 0.86 KDM4E (0.54) KDM4EALDH1A1GLAGAALMNA
SCHEMBL845125 0.86 ALDH1A1 (0.62) KDM4EALDH1A1GLAGAALMNA
SCHEMBL17950860 0.84 ALDH1A1 (0.40) KDM4EALDH1A1GLAGAALMNA
SCHEMBL18149317 0.84 TSHR (0.52) ALDH1A1KMT2AHSD17B10CASP1TSHR
SCHEMBL21358055 0.82 KDM4E (0.50) KDM4EALDH1A1GLAGAALMNA
SCHEMBL20399076 0.82 KDM4E (0.50) KDM4EALDH1A1GLAGAALMNA
SCHEMBL6491004 0.81 FTO (0.56) KDM4EALDH1A1GLAGAALMNA
SCHEMBL29416299 0.81 KDM4E (0.70) KDM4EALDH1A1GLAGAALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4448510-A1 INHIBITORS OF MET KINASE Kinnate Biopharma Inc. (US) 2024-10-23 EP disclosed
WO-2023114809-A1 INHIBITORS OF MET KINASE KINNATE BIOPHARMA INC. (US) 2023-06-22 WO disclosed